Last reviewed · How we verify
High grade squamous intraepithelial neoplasia of esophagus
Approved treatments
- Yervoy · Bristol-Myers Squibb
Yervoy blocks a protein called CTLA-4, which normally helps to turn off the immune system, allowing it to attack cancer cells. - Yervoy · Bristol-Myers Squibb
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- High grade squamous intraepithelial neoplasia of esophagus patent landscape — cliff calendar, originator estates, attackable patents
- High grade squamous intraepithelial neoplasia of esophagus treatment landscape brief
- High grade squamous intraepithelial neoplasia of esophagus treatment updates RSS
Frequently asked questions about High grade squamous intraepithelial neoplasia of esophagus
What drugs treat High grade squamous intraepithelial neoplasia of esophagus?
Tracked treatments include Yervoy.
What is the treatment for High grade squamous intraepithelial neoplasia of esophagus?
Standard treatment for High grade squamous intraepithelial neoplasia of esophagus includes Yervoy. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: High grade squamous intraepithelial neoplasia of esophagus patent cliff · High grade squamous intraepithelial neoplasia of esophagus CI report
- Treatment: Yervoy · Bristol-Myers Squibb
- Treatment: Yervoy · Bristol-Myers Squibb
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing